Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Haemonetics (HAE) Tops Q1 EPS by 5c
August 4, 2020 6:09 AM EDTHaemonetics (NYSE: HAE) reported Q1 EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $196 million versus the consensus estimate of $198.27 million.
FISCAL 2021 GUIDANCE The Company did not issue fiscal 2021 guidance due to the continued uncertainty... More
